Baihua Medicine: Jinhua Juxin acquired 20.68% shares of the company.

The announcement of Baihua Pharmaceutical stated that the company's controlling shareholder and actual controller, Mi Zaiqi, Mi Enhua, Yang Xiaoling, and Jinhua Juxin, signed a "Share Transfer Agreement". Jinhua Juxin acquired 79,525,100 shares, accounting for 20.68% of the total shares of the company, with a total transfer price of RMB 890 million, at a price of RMB 11.19 per share. Due to the company's profit distribution plan for the year 2025, a cash dividend of RMB 0.04 per share was distributed, and the transfer price was adjusted to RMB 887 million, with a transfer price of RMB 11.15 per share. The share transfer registration procedures were completed on June 9, 2026, and the company's controlling shareholder changed to Jinhua Juxin, with the actual controller being changed to the State-owned Assets Supervision and Administration Commission of Jinhua Municipal People's Government.